GoodRX calculated fill percentages for weight loss medications using a nationally representative sample of prescription fills. Data covered claims filed between Jan. 1 and Oct. 31. The organization also calculated the out-of-pocket cost for a 30-day supply of each medication based on the claims data. Learn more about the methodology here.
Medication fills for Zepbound have increased by more than 300% since the start of the year. The average out-of-pocket cost for patients was $230 per fill — the highest of any medication included in the analysis.
Wegovy fills also increased by more than 100% this year, with the average cost sitting at about $75.
In general, costs were higher for patients taking GLP-1s for weight loss versus diabetes. Patients filling Zepbound prescriptions for weight loss paid on average $141 more than those taking Mounjaro for diabetes, even though both medications have the same active ingredient.
In addition, 18% of patients with commercial insurance had no coverage for at least one brand-name weight loss medication.
View the full analysis here.
Interested in sharing your own thoughts? Take this quick survey about how your system is approaching GLP-1 medications here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
